PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
Li-Li Long(Southern Medical University), Zhong‐Yi Dong(Southern Medical University)
Cited by 33
Related Papers
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy
|Nature Communications|2023|58